MicroPort Inc.
The Patient Always Comes First. | |
| Public | |
| Traded as | SEHK: 853 |
| ISIN | 🆔 |
| Industry | Medical Devices |
| Founded 📆 | 1998 |
| Founder 👔 | |
| Headquarters 🏙️ | Shanghai, China |
Area served 🗺️ | |
Key people | Dr. Zhaohua Chang, CEO, Chairman, and Director Ms. Yan Zhang, President Mr. Qiyi Luo, CTO Mr. Bo Peng, CMO |
| Revenue🤑 |  US$217.3 Million (2017 interim)[1] |
| US$158.1 Million (2017 interim)[1] | |
| US$38.1 Million (2017 interim)[1] | |
| Members | |
Number of employees | 3000 (2017) |
| 🌐 Website | http://www.microport.com |
| 📇 Address | |
| 📞 telephone | |
MicroPort is a global developer, manufacturer, and marketer of medical devices that is headquartered in Shanghai, China. While originally focused on coronary intravascular devices, MicroPort now produces products for a range of medical fields including interventional cardiology, interventional radiology, orthopedics, electrophysiology, diabetes management, and surgical management.[2]
History[edit]
MicroPort was founded in 1998 by Zhaohua Chang, who currently serves as CEO, Chairman, and Director. The company rose to prominence due to the success of its Firehawk coronary stent line and is now one of the top global manufacturers of cardiac interventional devices.[3][4] Notably, it currently produces the only commercially available targeted drug eluting stent system, which uses a significantly reduced amount of drug than traditional drug eluting stents while maintaining effectiveness.[5][6][7] Additionally, as of Q4 2017, MicroPort is one of few medical device companies still developing a commercial coronary bioresorbable stent with ongoing clinical trials.[8][9][10] As of 2018, MicroPort has expanded internationally to other medical device industries, including orthopedics and cardiac rhythm management, and is valued at over US$1 Billion.[11][12]
Acquisitions[edit]
In 2014 MicroPort expanded operations in the United States by acquiring Wright Medical's OrthoRecon business to become the 6th largest international producer of orthopedic devices.[13] MicroPort's orthopedic business is based in Arlington, Tennessee and in 2018 has expanded its business into India.[14]
In 2018 MicroPort and LivaNova closed the sale of LivaNova's cardiac rhythm management business for $190M.[15]
In 2018 MicroPort purchased Lombard Medical, a US-based endovascular device company, from bankruptcy after it defaulted on loans in early 2018.[16]
References[edit]
- ↑ 1.0 1.1 1.2 "MicroPort 2017 Interim Report" (PDF). MicroPort.
- ↑ "About Us". MicroPort. MicroPort.
- ↑ "Company Overview of Shanghai MicroPort Medical (Group) Co., Ltd". Bloomberg.
- ↑ "Global Cardiac Catheters Market Share 2018 Microport, Terumo, Cook and Lepu". Publicist Report.
- ↑ Gao, RL (20 May 2013). "A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial". Eurointervention. 9 (1): 75–83. doi:10.4244/EIJV9I1A12. PMID 23685298.
- ↑ Xu, B; Gao, RL; Zhang, RY; Wang, HC; Li, ZQ; Yang, YJ; Ma, CS; Han, YL; Lansky, AJ; Huo, Y; Li, W; Leon, MB (March 2013). "Efficacy and safety of FIREHAWK® abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort". China Medical Journal. 126 (6): 1026–32. PMID 23506573.
- ↑ "Round Table Expert - Firehawk Stent, proven fast healing from TARGET clinical program". EuroPCR.
- ↑ Regazzoli, Damiano; Leone, Pier Pasquale; Colombo, Antonio; Latib, Azeem (9 August 2017). "New generation bioresorbable scaffold technologies: an update on novel devices and clinical results". Journal of Thoracic Disease. 9: S979–S985. doi:10.21037/jtd.2017.07.104.
- ↑ Wendling, Patrice. "Boston Scientific Halts Bioabsorbable-Scaffold Program". Medscape. WebMD.
- ↑ Fornell, Dave. "Abbott Will End Sales of Absorb Bioresorbable Stent". Diagnostic and Interventional Cardiology. Scranton Gillette Communications.
- ↑ "Surprising MicroPort Orthopedics". Orthopedics This Week.
- ↑ "LivaNova closes $190 CRM sale to MicroPort". Mass Device.
- ↑ "MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business". Cision PR Newswire.
- ↑ "MicroPort forays into orthopaedic implants". The Hans India.
- ↑ "LivaNova closes $190 CRM sale to MicroPort". Mass Device.
- ↑ "Lombard Medical Operations Acquired by MicroPort Scientific Corporation in a Restructuring Transaction". PR Newswire Association.
This article "MicroPort" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:MicroPort. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
|
This page exists already on Wikipedia. |
